$7.53
0.7511.06%
Last update: Nov 6, 5:20 PM
Cartesian Therapeutics Inc
RNACNASDAQ
The average analyst price target for Cartesian Therapeutics is $36.11, 385.3% above the current price. Of 9 analysts, 9 rate it Buy. Targets range from $16 to $44. The latest change came on May 26, 2026, when Needham lowered its price target on Cartesian Therapeutics from $42 to $40 and kept a Buy rating.
Price Target Range — 11 Quarters
Analyst Consensus — 9 Analysts
Rating Trend — Last 9 Months
